— Know what they know.
Not Investment Advice

PXMD OTC

PaxMedica, Inc. Common Stock
1W: -0.0% 1M: -28.6% 3M: -0.0% YTD: +400.0% 1Y: +400.0% 3Y: -100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 45 · $63132 mcap · 11M float · 0.016% daily turnover · Short 59% of daily vol

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ — Grade A+
Profitability
—
Balance Sheet
0
Earnings Quality
30
Growth
—
Value
15
Momentum
—
Safety
0
Cash Flow
—

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-177.27
Distress Zone
Piotroski F-Score
2/9
✗ ✗ ✗ ✓ ✓ ✗ ✗ ✗ ✗
Beneish M-Score
—
—
Ohlson O-Score
72.72
Bankruptcy prob: 100.0%
High Risk
Credit Rating
CCC
Score: 18.1/100
Trend: Deteriorating
Earnings Quality
—
OCF/NI: 0.53x
Accruals: -280.6%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. PXMD scores -177.27, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. PXMD scores 2/9, suggesting weak financial fundamentals — the company fails the majority of these accounting tests. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. PXMD's implied 100.0% bankruptcy probability signals significant financial distress. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. PXMD receives an estimated rating of CCC (score: 18.1/100), with a deteriorating trend.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
-0.00x
PEG
-0.00x
P/S
0.00x
P/B
0.00x
P/FCF
-0.18x
P/OCF
—
EV/EBITDA
-0.08x
EV/Revenue
—
EV/EBIT
-0.08x
EV/FCF
-0.14x
Earnings Yield
-1059.91%
FCF Yield
-559.36%
Shareholder Yield
0.00%
Graham Number
—
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. PXMD currently has negative earnings — the P/E ratio is not meaningful.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
1.000
NI / EBT
×
Interest Burden
1.000
EBT / EBIT
×
EBIT Margin
—
EBIT / Rev
×
Asset Turnover
0.000
Rev / Assets
×
Equity Multiplier
12.985
Assets / Equity
=
ROE
-7716.2%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. PXMD's ROE of -7716.2% is driven by A tax burden ratio of 1.00 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
—
Price/Value
—
Margin of Safety
—
Premium
—

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1030 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.00
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
828.6%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
Howard J. Weisman
Chief Executive Officer
$478,125 $333,024 $1,050,224
Michael Derby
Former Executive Chairman
$208,125 $277,515 $671,872
Stephen D. Sheldon
Chief Financial Officer
$325,000 $185,020 $635,874
David W. Hough
Chief Medical Officer
$75,938 $69,010 $388,610
Zachary Rome Operating
ief Operating Officer
$64,038 $185,020 $363,475

CEO Pay Ratio

1:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $1,050,224
Avg Employee Cost (SGA/emp): $2,038,333
Employees: 6

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
6
+100.0% YoY
Revenue / Employee
—
Profit / Employee
$-3,048,333
NI: $-18,290,000
SGA / Employee
$2,038,333
Avg labor cost proxy
R&D / Employee
$652,500
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
ROE -4.8% -153.4% -8.1% -10.6% -19.0% -10.5% -9.7% -77.2% -77.16%
ROA -1.9% -7.6% -4.3% -4.7% -3.8% -4.6% -4.7% -5.9% -5.94%
ROIC 70.5% 3.7% -105.8% -13.8% 121.7% 9.6% 28.6% 5.7% 5.72%
ROCE -4.8% -153.3% -6.9% -8.8% 476.1% -4.7% -10.7% 13.5% 13.50%
Gross Margin — — — — — — — — —
Operating Margin — — — — — — — — —
Net Margin — — — — — — — — —
EBITDA Margin — — — — — — — — —
FCF Margin — — — — — — — — —
OCF Margin — — — — — — — — —
ROIC Economic snapshot only 6.75%
Cash ROA snapshot only -11.66%
Valuation
Metric Trend Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
P/E Ratio -1.92 -1.46 -1.18 -0.48 -0.27 -0.31 -0.21 -0.09 -0.000
P/S Ratio — — — — — — — — 0.000
P/B Ratio 9.22 224.56 9.53 5.08 -8.80 1.66 3.18 -0.92 0.000
P/FCF -14.01 -5.27 -3.17 -1.10 -0.42 -0.52 -0.35 -0.18 -0.179
P/OCF — — — — — — — — —
EV/EBITDA -1.45 -1.36 -1.07 -0.43 -0.30 -0.05 -0.12 -0.08 -0.076
EV/Revenue — — — — — — — — —
EV/EBIT -1.45 -1.36 -1.06 -0.42 -0.29 -0.05 -0.12 -0.08 -0.076
EV/FCF -10.57 -4.89 -2.85 -0.97 -0.46 -0.08 -0.20 -0.14 -0.144
Earnings Yield -52.0% -68.3% -85.0% -2.1% -3.7% -3.3% -4.8% -10.6% -10.60%
FCF Yield -7.1% -19.0% -31.6% -90.9% -2.4% -1.9% -2.9% -5.6% -5.59%
Shareholder Yield snapshot only 0.00%
Leverage & Solvency
Metric Trend Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
Current Ratio 1.66 1.05 2.64 2.12 0.99 3.16 2.40 0.38 0.379
Quick Ratio 1.66 1.05 2.64 2.12 0.99 3.16 2.40 0.38 0.379
Debt/Equity 0.07 1.60 0.61 0.74 -2.95 0.00 0.00 -0.00 -0.000
Net Debt/Equity -2.26 -15.89 -0.97 -0.62 — -1.39 -1.37 — —
Debt/Assets 0.03 0.08 0.32 0.32 0.49 0.00 0.00 0.00 0.000
Debt/EBITDA -0.01 -0.01 -0.08 -0.07 -0.09 -0.00 -0.00 -0.00 -0.000
Net Debt/EBITDA 0.47 0.10 0.12 0.06 -0.02 0.26 0.09 0.02 0.018
Interest Coverage -8756.30 -3184.84 -2237.75 -1832.35 -1342.47 -1994.54 -3464.39 -13490.45 -13490.451
Equity Multiplier 2.50 20.26 1.88 2.27 -6.02 1.68 2.43 -0.44 -0.442
Cash Ratio snapshot only 0.154
Debt Service Coverage snapshot only -13490.451
Defensive Interval snapshot only 7.7 days
Efficiency & Turnover
Metric Trend Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Inventory Turnover — — — — — — — — —
Receivables Turnover — — — 0.00 0.00 — — 0.00 0.000
Payables Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 —
DSO — — — — — — — — —
DIO — — — — — — — — —
DPO — — — — — — — — —
Cash Conversion Cycle — — — — — — — — —
Cash Velocity snapshot only 0.000
Growth (YoY)
Metric Trend Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
Revenue — — — — — — — — —
Net Income — — — — -53.4% -9.6% 11.6% 26.4% 26.43%
EPS — — — — 14.8% 89.5% 91.1% 91.7% 91.73%
FCF — — — — -6.1% -1.3% -42.4% 10.9% 10.88%
EBITDA — — — — -51.2% -8.1% 10.5% 25.6% 25.64%
Op. Income — — — — -5.2% -1.1% -34.9% -2.5% -2.47%
OCF Growth snapshot only 10.88%
Asset Growth snapshot only -84.46%
Equity Growth snapshot only -1.80%
Debt Growth snapshot only -1.00%
Shares Change snapshot only 7.89%
Growth Quality
Metric Trend Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
Revenue Stability — — — — — — — — —
Earnings Stability — — — — — — — — —
Margin Stability — — — — — — — — —
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — —
Earnings Smoothness — — — — — — — — —
ROE Trend — — — — — — — — —
Gross Margin Trend — — — — — — — — —
FCF Margin Trend — — — — — — — — —
Sustainable Growth Rate — — — — — — — — —
Internal Growth Rate — — — — — — — — —
Cash Flow Quality
Metric Trend Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
OCF/Net Income 0.14 0.28 0.37 0.44 0.64 0.59 0.60 0.53 0.528
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
FCF/Net Income snapshot only 0.528
CapEx/Revenue — — — — — — — — —
Accruals Ratio -1.65 -5.46 -2.71 -2.63 -1.38 -1.91 -1.91 -2.81 -2.806
Sloan Accruals snapshot only -1.245
Dividends & Buybacks
Metric Trend Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — —
FCF Payout Ratio — — — — — — — — —
Total Payout Ratio — — — — — — — — —
Div. Increase Streak — — — — — — — — —
Chowder Number — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -29.9% -24.7% -49.8% -1.2% -1.1% -2.1% -1.6% -2.4% -2.39%
Total Shareholder Return -29.9% -24.7% -49.8% -1.2% -1.1% -2.1% -1.6% -2.4% -2.39%
DuPont Factors
Metric Trend Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
Interest Burden (EBT/EBIT) 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.000
EBIT Margin — — — — — — — — —
Asset Turnover 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.000
Equity Multiplier 2.50 20.26 1.88 2.27 4.98 2.26 2.05 12.99 12.985
Per Share
Metric Trend Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
EPS (Diluted TTM) $-21.24 $-23.57 $-27.60 $-27.89 $-18.10 $-2.47 $-2.45 $-2.31 $-2.31
Book Value/Share $4.42 $0.15 $3.41 $2.63 $-0.55 $0.46 $0.16 $-0.24 $2.04
Tangible Book/Share $4.42 $0.15 $3.41 $2.63 $-0.55 $0.46 $0.16 $-0.24 $-0.24
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $-2.91 $-6.55 $-10.25 $-12.15 $-11.54 $-1.46 $-1.46 $-1.22 $-6.48
OCF/Share $-2.91 $-6.55 $-10.25 $-12.15 $-11.54 $-1.46 $-1.46 $-1.22 $-6.48
Cash/Share $10.31 $2.69 $5.36 $3.57 $1.19 $0.64 $0.22 $0.04 $2.83
EBITDA/Share $-21.23 $-23.56 $-27.26 $-27.59 $-17.84 $-2.44 $-2.45 $-2.31 $-2.31
Debt/Share $0.29 $0.25 $2.07 $1.93 $1.63 $0.00 $0.00 $0.00 $0.00
Net Debt/Share $-10.02 $-2.44 $-3.29 $-1.63 $0.44 $-0.64 $-0.22 $-0.04 $-0.04
Academic Models
Metric Trend Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
Altman Z-Score — — — — — — — — -177.269
Altman Z-Prime snapshot only -397.868
Piotroski F-Score 2 2 2 2 1 4 2 2 2
Beneish M-Score — — — — — — — — —
Ohlson O-Score snapshot only 72.718
Net-Net WC snapshot only $-0.24
Credit
Metric Trend Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Current
Credit Rating snapshot only CCC
Credit Score 28.37 19.70 29.21 28.20 17.79 38.11 36.53 18.10 18.102
Credit Grade snapshot only 17
Credit Trend snapshot only -10.102
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 9
Sector Credit Rank snapshot only 9

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms